港股異動 | 萬洲國際(0288.HK)升超5% 股價創7個月新高
格隆匯3月8日丨萬洲國際(0288.HK)逆勢拉昇至5.14%,報7.36港元創7個月新高價,總市值1085億港元。招銀國際日前指出,預測萬洲2021財年調整後淨利潤在美國市場推動下將會反彈23%,主要由於生豬價格上漲和疫情相關費用減少。如果FDA授權使用強生疫苗,會加速美國疫苗接種,這將成為一個催化劑。瑞銀重申萬洲國際“買入”評級,目標價升至11.4港元。稱萬洲 最差的時刻已過去,未來複蘇可期,認為在短期內收入將受到疫情影響減少及原材料價格下跌等因素所推動。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.